Rondo Therapeutics Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
Rondo Therapeutics is a Hayward, California-based biotechnology company focused on immuno-oncology therapies for solid tumors. It concentrates on bispecific antibodies designed to attack tumors while sparing healthy tissue, addressing unmet needs in solid-tumor treatment. The organization describes itself as a small to mid-sized team pursuing next-generation platforms in oncology research. In December 2024, it announced a collaboration with Lilly to develop co-stimulatory bispecific antibodies for solid tumors, combining Rondo's proprietary CD28 co-stimulatory platform with Lilly's development and commercialization capabilities. Rondo Therapeutics also emphasizes a collaborative, merit-based culture that supports career growth.